Postoperative tamoxifen for ductal carcinoma in situ

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  McCallum, Iain ^a   Craig, Wendy ^b   Bruce, Julie ^c  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c College of Life Sciences and Medicine ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL TRIAL; ENDOMETRIUM CARCINOMA; HUMAN; INTRADUCTAL CARCINOMA; PARTIAL MASTECTOMY; POSTOPERATIVE CARE; QUALITY OF LIFE; REVIEW; STROKE; SYSTEMATIC REVIEW; THROMBOEMBOLISM;

EID: 70349087828     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007847     Document Type: Review

References (8)

1. Bijker N, Peterese JL, Duchateau L, et al. Histological type andmarker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ. Brithish Journal of Cancer 2001;84:539-544 (Pubitemid 32215883)
2. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. Available from www.cochrane-handbook.org.. The Cochrane Collaboration, 2008.
3. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer. Cochrane Database of Systematic Reviews 2001, issue 1. [CD: 000486]
4. Fisher D, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W. Lumpectomy and radiation therapy for treatment of intraductal breast cancer: findings from adjuvant surgical national breast & bowel project B17. Journal of Clinical Oncology 1998;16:441-452 (Pubitemid 28135585)
5. Julien JP, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ - first result of the EORTC phase III randomised trial 10853. EORTC Breast cancer cooperative group & EORTC Radiotherapy group. Lancet 2000;355:528-533
6. Kerlikowske K, Molinaro A, Cha I, Ljung BM, Ernster VL, Stewart K, et al.Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. Journal of the National Cancer Institute 2003;95:1692-1702 (Pubitemid 37509078)
7. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995;76:1197-2000.
8. van Steenbergen LN, Voogd AC, Roukema JA, Louwman WJ, Duijm LE, Coebergh JW, et al. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Research and Treatment 2008;31 May:e-published ahead of print.